CHUNDSELL MEDICALS
Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatypeยฎ Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. The Prostatypeยฎ Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
CHUNDSELL MEDICALS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2007-01-01
Address:
Kista, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.chundsell.com
Total Employee:
1+
Status:
Active
Contact:
(460)820-8188
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Google Cloud Japanese Yen Debian Loopia DNS
Current Employees Featured
Investors List
Creathor Ventures
Creathor Ventures investment in Venture Round - Chundsell Medicals
Almi Invest
Almi Invest investment in Venture Round - Chundsell Medicals
Creathor Ventures
Creathor Ventures investment in Venture Round - Chundsell Medicals
More informations about "Chundsell Medicals"
Chundsell Medicals - Crunchbase Company Profile & Funding
Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer โฆSee details»
Corporate Governance - Prostatype Genomics
Corporate Governance Prostatype Genomics AB (the โCompanyโ) is a public company, registered in Sweden, with organization number 556726-0285 and its Legal Entity Identifier (LEI) is โฆSee details»
Chundsell Medicals - VentureRadar
Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer โฆSee details»
Chundsell Medicals - Overview, News & Similar companies
Who is Chundsell Medicals. Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and โฆSee details»
Chundsell Medicals Company Profile - Office Locations ... - Craft
Chundsell Medicals is a company working with prostate cancer patients. It develops Prostatype, a test system based on a gene expression test, which measures the expression of three โฆSee details»
Home - Prostatype Genomics
Prostatype Genomics Prostate cancer is one of the most common forms of cancer and approximately 1.3 million men are diagnosed annually. Prostatype Genomics AB specializes in the development, manufacturing, and marketing โฆSee details»
Chundsell Medicals | Company | Mindmaps
Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer โฆSee details»
Chundsell Medicals - Funding, Financials, Valuation & Investors
Jan 1, 2015 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2015: โฆSee details»
Chundsell Medicals - Contacts, Employees, Board Members
Chundsell Medicals has 4 current employee profiles, including Chief Technology Officer Zhuochun Peng. Zhuochun Peng Chief Technology Officer Joakim Hagvik Sales and Marketing ManagerSee details»
Chundsell Medicals AB: Drug pipelines, Patents, Clinical trials
Jun 17, 2023 Explore Chundsell Medicals AB with its drug pipeline, therapeutic area, technology platform, .See details»
Chundsell Medicals (company) | Nordic 9
Chundsell Medicals (company). Chundsell Medicals AB was founded in 2007 as a spin off from Cancer Center Karolinska (Karolinska Institutet, Stockholm, Sweden) in order to transfer the โฆSee details»
Board of directors - Prostatype Genomics
Board of directors Anders Lundberg Chairman of the Board (member of the board since 2017) About:M.Sc. Mechanical Engineering, KTH, Stockholm, Sweden. Founder and CEO of a โฆSee details»
Chundsell Medicals AB - HealthManagement.org
About Us Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate โฆSee details»
Chundsell Medical โ 20 Years of Innovation
Sep 25, 2020 Li has since set up Chundsell Medical, having identified a method that distinguishes between aggressive and low risk prostate cancers and can therefor be a โฆSee details»
Chundsell Medicals - Crunchbase
Molecular diagnostics for cancerSee details»
The right contacts led the way | Karolinska Institutet
Chundsell Medical. One of the keys to success was meeting US professor Patric O Brown, responsible for a method that enables the rapid, simultaneous examination of activity among โฆSee details»
Meet Chunde Li - Chundsell Medical - KI Innovations
Jun 17, 2019 He is behind a unique test to distinguish benign prostate cancer from aggressive forms of the condition that require immediate treatment. Finding the right contacts at the right โฆSee details»
Bengt Håkan Englund: Positions, Relations and Network
Oct 30, 2024 Bengt Håkan Englund is currently the Chief Executive Officer & Owner at JDS Invest AB, Chairman at Secureappbox AB, Director at Antrad Medical AB, Director at โฆSee details»
Chundsell Medicals - Tech Stack, Apps, Patents & Trademarks
Molecular diagnostics for cancerSee details»
Improving the Prediction of Prostate Cancer Overall Survival by ...
Jan 5, 2016 Chundsell Medicals AB and Ridgeview Instruments AB provided support in the form of salaries for authors ZP and KA, respectively, but did not have any additional role in the โฆSee details»